This company listing is no longer active
Biodexa Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Biodexa Pharmaceuticals has a total shareholder equity of £7.5M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £9.7M and £2.2M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
| Interest coverage ratio | n/a |
| Cash | UK£6.42m |
| Equity | UK£7.49m |
| Total liabilities | UK£2.19m |
| Total assets | UK£9.68m |
Financial Position Analysis
Short Term Liabilities: BDRX's short term assets (£8.7M) exceed its short term liabilities (£1.6M).
Long Term Liabilities: BDRX's short term assets (£8.7M) exceed its long term liabilities (£546.0K).
Debt to Equity History and Analysis
Debt Level: BDRX is debt free.
Reducing Debt: BDRX has no debt compared to 5 years ago when its debt to equity ratio was 4.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if BDRX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BDRX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.